Elastagen
In 2018, Elastagen was acquired by global biopharma Allergan, in a deal totalling AU $400 million (US $265 million) with further milestone payments to come.
Therapeutic Area:
AcquiredMedical Devices
In 2018, Elastagen was acquired by global biopharma Allergan, in a deal totalling AU $400 million (US $265 million) with further milestone payments to come.
